Cindy Eckert, Sprout Pharmaceuticals CEO (Rick Kern/Getty Images for Inc)
FDA mulls regulatory action on Sprout's 'female Viagra' after adverse events spike
Before there was Biogen’s Aduhelm, there was Sprout Pharmaceuticals’ “female Viagra” pill Addyi. Both FDA-approved drugs stirred up significant controversy because their approvals were based …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
